The Cord Blood Registry is on the forefront of the first FDA clinical trial of its kind. They are investigating whether the stem cells in cord blood may be able to reverse the effects of autism. Here's the theory.
Heather Brown from the Cord Blood Registry said, "Stem cells may have the ability to regulate the immune system or they may regulate the nervous system." "This initial pilot study will accept 30 children who have autism not caused by a genetic factor."
This study will only involve children whose parents have banked their own cord blood at birth. So they can receive infusions of their own stem cells, which they can't reject. The hope is the new stem cells, which have not been exposed to infection or chemicals, will be able to help patients rev up their own ability to repair damage.
Copyright 2012 KCBD. All rights reserved.